Skip to content
Approximately two years ago, several owners of independent repair shops — ones not affiliated with a specific manufacturer — felt the need to band together to form a group that would allow them to better promote their business interests while also providing a more consistent service experience for fleets. ...
Amazon is challenging the Pentagon’s awarding of the $10 billion JEDI cloud contract to Microsoft, alleging Trump’s animus for Amazon caused Pentagon officials, “consciously or subconsciously,” to award the contract to Microsoft. ...
Shares of small-cap immunotherapy company Nantkwest Inc (NASDAQ: NK), a leading producer of clinical dose forms of off-the-shelf natural killer cell therapies, were adding to Monday's gains in Tuesday's session. NantKwest and its affiliate ImmunityBio are in "active discussions" with the FDA about developing therapies and vaccines to combat the COVID-19 pandemic, the companies said in a Tuesday press release. ImmunityBio will contribute its expertise in vaccine development and NK cell activation, while NantKwest will pitch in with its off-the-shelf cell-based therapies.ImmunityBio and NantKwest said they have developed immunomodulator regimens for COVID-19 based on the biological stage of the patient's infection -- mild, moderate and severe or critically ill. Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.NantKwest, ImmunityBio's COVID-19 Strategy With the mild-to-moderate stage of infection, the companies said NK and T cell stimulation should work and...
Remdesivir, the Gilead Sciences (GILD) drug also known as "GS-5734," and originally developed as a treatment for Ebola, has been hailed as perhaps the best hope (currently under investigation) to help stop the spread of the SARS-CoV-2 coronavirus.Remdesivir is currently undergoing the fastest of fast-track authorizations to develop the drug and test its effectiveness against COVID-19. The most recent data on the drug's effectiveness, derived from an April 10 New England Journal of Medicine (NEJM) report and subsequent updates, suggests that the drug may have at least some efficacy in combating the novel coronavirus.To date, Gilead has made remdesivir available to about 1,800 patients globally. A variety of organizations are conducting formal clinical trials of the drug, the government of China and Gilead itself among them, and initial results from at least five such trials are expected to be arriving throughout April and May.Summarizing what we know so far, analyst Hartaj...
Texas energy regulators on Tuesday morning started to hear from dozens of energy executives on an initiative calling for the state to mandate an output cut to stem the sharpest oil price drop in decades. Oil and gas companies are gushing red ink and cutting tens of thousands of workers as oil prices have crashed to about $22 a barrel from $61 in January. On Monday, Texas refiner Valero Energy Corp forecast a first-quarter loss of up to $2.1 billion on falling demand....
Texas energy regulators listened as top energy executives on Tuesday backed a plan to cut the state's output by 1 million barrels per day without tipping their hands through more than five hours of sometimes dire testimony. Oil and gas companies are gushing red ink and cutting tens of thousands of workers as oil prices tumble, prompting regulators in the largest U.S. oil producing state to wade into global oil politics and consider the calls for cuts. U.S. crude oil prices fell during the hearing to under $20 a barrel at one point, a nearly 18-year low....
